Patient Attitudes Regarding the Cost of Illness in Cancer Care

The Oncologist
Barry R MeisenbergDavid Weng

Abstract

The cost of illness in cancer care and the subsequent distress has attracted scrutiny. Guidelines recommend enhanced discussion of costs, assuming this will reduce both stress and costs. Little is known about patient attitudes about cost considerations influencing treatment decisions. A convenience-sample survey of patients currently receiving radiation and/or intravenous chemotherapy at an outpatient cancer center was performed. Assessments included prevalence and extent of financial burden, level of financial distress, attitudes about using costs to influence treatment decisions, and frequency or desirability of cost discussions with oncologists. A total of 132 participants (94%) responded. Overall, 47% reported high financial stress, 30.8% felt well informed about costs prior to treatment, and 71% rarely spoke to their oncologists about cost. More than 71% of patients did not want either society's or personal costs to influence treatment, and this result did not change based on degree of financial stress. Even when asked to assume that lower cost regimens were equally effective, only 28% would definitely want the lower cost regimen. Patients did not believe it was the oncologist's duty to perform cost discussions. Even insur...Continue Reading

References

Aug 10, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Christopher J LongoA Paul Williams
Jul 8, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Neal J MeropolUNKNOWN American Society of Clinical Oncology
Jan 6, 2010·Health Affairs·Peter J NeumannPeter Ubel
May 27, 2011·The New England Journal of Medicine·Thomas J Smith, Bruce E Hillner
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cathy J Bradley
Nov 28, 2012·Journal of Oncology Practice·Andrea J BullockMary K Buss
Oct 18, 2013·The New England Journal of Medicine·Peter A UbelS Yousuf Zafar
Dec 19, 2013·Journal of Medicine and the Person·Jonas A de Souza, Yu-Ning Wong
Dec 25, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stacie B DusetzinaNancy L Keating
Mar 26, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reshma JagsiSarah T Hawley
Mar 29, 2014·The Oncologist·Fumiko ChinoS Yousuf Zafar
May 20, 2014·Journal of Oncology Practice·Christine M BestvinaS Yousuf Zafar
May 28, 2014·Annals of Internal Medicine·Laura B VaterYael Schenker
Jul 25, 2014·JAMA : the Journal of the American Medical Association·Bridget M Kuehn
Oct 3, 2014·The Oncologist·Blair IrwinJeffrey Peppercorn
Jul 17, 2015·JAMA Oncology·Veena Shankaran, Scott Ramsey

❮ Previous
Next ❯

Citations

Oct 22, 2016·Journal of the National Cancer Institute·Cheryl K AlticeK Robin Yabroff
Nov 12, 2016·Journal of Cancer Survivorship : Research and Practice·Susan CattLesley Fallowfield
Apr 24, 2018·Oncology Nursing Forum·Anne Katz
Aug 24, 2018·Journal of Oncology Practice·Fumiko ChinoS Yousuf Zafar
May 18, 2019·American Society of Clinical Oncology Educational Book·Fumiko Chino, S Yousuf Zafar
Jun 5, 2019·Journal of Oncology Practice·Rahma WarsameJon C Tilburt
Dec 19, 2019·Journal of Adolescent and Young Adult Oncology·Catherine Fiona MacphersonKristin Stegenga
Aug 13, 2020·Psycho-oncology·Beverley M EssueClaire de Oliveira
Sep 15, 2020·Journal of the American Heart Association·Rohan KheraKhurram Nasir
Aug 9, 2017·Journal of Psychosocial Oncology·Erin M Ellis, Ashley Varner
Nov 5, 2020·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Hannah K BassettAlan R Schroeder
May 4, 2021·World Neurosurgery·Julie L KoenigErqi L Pollom
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J WitteE C Winkler
Aug 17, 2021·JACC. CardioOncology·Javier Valero-ElizondoKhurram Nasir
Aug 15, 2020·Mayo Clinic Proceedings. Innovations, Quality & Outcomes·Nandita KheraJoan M Griffin
Sep 22, 2021·JAMA Network Open·Hannah K BassettAlan R Schroeder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Studies in Health Technology and Informatics
Denise GoldsmithCharles Safran
International Journal of Radiation Oncology, Biology, Physics
L R CoiaT J Priestman
© 2021 Meta ULC. All rights reserved